openPR Logo
Press release

Global Neurological Biomarkers Market - Forecast to 2026

Neurological Biomarkers Market

Neurological Biomarkers Market

The findings reviewed by GME stated that the Global Neurological Biomarkers Market would grow at a CAGR value of 10.2 percent from 2021 to 2026. Today, with advancing technology and neurological applications, the awareness about the effectiveness of biomarker signature in diagnosing diseases or disorders is also increasing. Besides the beneficial features attributed to the neurological biomarkers, the annual exponential increase in the rate of neurological diseases is also accelerating growth in the market.

Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on “Global Neurological Biomarkers Market - Forecast to 2026” https://www.globalmarketestimates.com/market-report/global-neurological-biomarkers-market-3181

By Application (Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Autism Spectrum Disorders, and Others), By Type (Genomic, Proteomic, Metabolomic, Imaging, and Others), By End-User (Hospital Laboratories, Independent Clinical Diagnostic Centers, Research Organizations, and Others), By Region (North America, Europe, Asia Pacific, MEA, and CSA); Competitive Landscape, Company Market Share Analysis, and Competitor Analysis
Key Market Insights
• Alzheimer's disease is analyzed to hold predominance in the market due to the rise in populaces of geriatric population.
• Genomic type is substantially used to identify and diagnose biomarkers and subsequently identify various diseases and disorders, thus holding the market's largest share.
• Hospital laboratories hold the largest share and have their dominance in the market because they are a part of more outstanding medical infrastructure and investment.
• North America has a significant revenue proportion in the neurological biomarkers industry due to the presence of several leading major players in this area.
• Acumen Pharmaceuticals, Abbott, Banyan Biomarkers, Inc., Athena Diagnostics, QIAGEN, AbaStar MDx, Inc., Alseres Pharmaceuticals, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and Myriad RBM, Inc. are few prominent competitors in the market.

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-neurological-biomarkers-market-3181

Application Outlook (Revenue, USD Billion, 2021-2026)
• Alzheimer’s Disease
• Parkinson’s Disease
• Multiple Sclerosis
• Autism Spectrum Disorders
• Others

Type Outlook (Revenue, USD Billion, 2021-2026)
• Genomic
• Proteomic
• Metabolomic
• Imaging
• Others

End-User Outlook (Revenue, USD Billion, 2021-2026)
• Hospital Laboratories
• Independent Clinical Diagnostic Centers
• Research Organizations
• Others

Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
• The US.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA

Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com/
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php

B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India

Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Neurological Biomarkers Market - Forecast to 2026 here

News-ID: 2289915 • Views: 567

More Releases from Global Market Estimates Research & Consultants

Allogeneic Cell Therapy Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Allogeneic Cell Therapy Market is projected to grow from USD 994.9 million in 2022 to USD 1,570.1 million by 2027 at a CAGR of 9.6% from 2022 to 2027. Browse 155 Market Data Tables and 133 Figures spread through 156 Pages and in-depth TOC on "Global Allogeneic Cell Therapy Market - Forecast to 2027'' https://www.globalmarketestimates.com/market-report/allogeneic-cell-therapy-market-3894
MHC Multimers Market Size & Analysis
According to a new market research report published by Global Market Estimates, the Global MHC Multimers Market is projected to grow at a CAGR value of 4.8% from 2022 to 2027. Immudex, Sigma-Aldrich, JPT Peptide Technologies, Creative Biolabs, ProImmune, MBL International, BioLegend, Altor BioScience Corporation, Immunaware, Bio X Cell, and Sanquin, among others, are the some of the key players in the MHC multimers market. Browse 155 Market Data Tables and
Oncology Sequencing Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Oncology Sequencing Market is projected to grow at a CAGR of 13.5% from 2022 to 2027. Thermo Fisher Scientific, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd., QIAGEN, BGI, Agilent Technologies, Guardant Health, Biocept, Inc., Myriad Genetics, Inc., and eviCore healthcare among others, are some key players in the oncology sequencing market. Browse 151 Market Data Tables and
Global AI in Education Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global AI in Education Market is projected to grow from USD 3.79 Billion in 2022 to USD 20.54 Billion in 2027 at a CAGR value of 45.6% from 2022 to 2027. The increasing use of mobile devices to access educational programs and study materials, such as smartphones, tablets, and laptops, has prompted software developers to create software that

All 5 Releases


More Releases for Biomarkers

Predisposition Biomarkers Market - Rapid Growth at Deep Value Price from 2020-20 …
"The new report has been added by qyresearch.com to provide detailed insight into the global Predisposition Biomarkers market. The study will help to get a better understanding about the Predisposition Biomarkers industry competitors, a channel for the distribution, Predisposition Biomarkers growth potential, potentially disruptive trends, Predisposition Biomarkers industry product innovations, market size value/volume (regional/country level, Predisposition Biomarkers industry segments), market share of top players/products. Due to the pandemic, we have included
3rd World Biomarkers Summit
We cordially invite you to the 3rd World Biomarkers Summit to be held at Rome, Italy on April 22-23, 2020. The 2020 edition of the Biomarkers conference will move forward with the theme “Biomarker as a future protagonist”. Biomarkers 2020 concentrates on procuring emerging researches in the sector of medicine and health brought to us via applications of biomarkers. Scientists, Young researchers, pharmaceutical industrialists and medical professionals are expected to
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Global Companion Diagnostic Cancer Biomarkers Market by types (Protein Biomarker …
Global Companion Diagnostic Cancer Biomarkers Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. The report, titled Companion Diagnostic Cancer Biomarkers presents an in-depth study of the Companion Diagnostic Cancer Biomarkers market. Providing a brief history about the market, the report analyses the entire value chain of the market and points out the key drivers and restraints affecting the growth of the market during the forecast period. The report
Global Biomarkers Market Propelled by Growing Usage of Biomarkers in Medical Are …
A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions and help
Biomarkers Summit
SMi present their 4th annual conference on Biomarkers Summit Monday 31st January & Tuesday 1st February 2011 Crowne Plaza The-City, London, UK Don’t Miss Out - Visit to register your place today http://www.smi-online.co.uk/preclinical-biomarkers.asp Sponsored by Caprotec Cell Signalling Technology GVK Bio Selventa Millipore Quest Diagnostics RBM SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out